SHUBHAM PANT to Risk Assessment
This is a "connection" page, showing publications SHUBHAM PANT has written about Risk Assessment.
Connection Strength
0.059
-
Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab. Am J Clin Oncol. 2016 12; 39(6):614-618.
Score: 0.059